TOP2A and acute myeloid leukemia: Furthermore, in different cancer types [92, 93], the downregulation of TOP2A was found to be related to the inhibition of cell proliferation, which is in agreement with our findings of cell proliferation in the 3D BM niche-like AML model (CFSE data) (Fig. 5B).